You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Test Information
Home / Tests / Critical Infectious Diseases / Xpert Xpress CoV-2/Flu/RSV plus

Xpert® Xpress CoV-2/Flu/RSV plus

Actionable, rapid respiratory results to meet the challenges of the ongoing pandemic

Xpert<sup>® </sup>Xpress CoV-2/Flu/RSV <em>plus</em>

The Need

  • Rapidly detect SARS-CoV-2, including emerging variants, to provide a timely, effective triage
  • Respiratory tract infections require an accurate diagnosis to ensure that patients receive appropriate treatment
  • Rapidly differentiate Flu A, Flu B, RSV, and COVID-19.  Identify potential cases of co-infections during respiratory season

The Solution

  • Actionable detection of SARS-CoV-2 in as little as 25 minutes, with results for all four pathogens in just 36 minutes
  • Robust design with three distinct gene targets for SARS-CoV-2:  N2, E, RdRP to offer broader coverage against mutations
  • Rapid sample to answer provides actionable results from a single sample with less than one minute of hands-on time
  • Standardization of results between the central lab and near-patient testing sites

The Impact

  • Ensures that patients receive appropriate treatment in a timely manner
  • Supports clinicians with broader coverage for variants
  • Single cartridge with an easy-to-use workflow, enabling hospitals to effectively manage limited resources

For Use Under an Emergency Use Authorization (EUA) only. This test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Full test runtime is 36 minutes. SARS-CoV-2 positive results available in as soon as 25 minutes with early assay termination.

Ordering Info

Xpert® Xpress CoV-2/Flu/RSV plus

Number of Tests: 10  

Catalog #: XP3COV2/FLU/RSV-10

Frequently Asked Questions

How is the Xpert Xpress CoV-2/Flu/RSV plus product different from the existing Xpert Xpress SARS-CoV-2/Flu/RSV product?

What sample types and collection devices can be used with Xpert Xpress CoV-2/Flu/RSV plus?

What are my options for Viral Transport Media for Xpert Xpress CoV-2/Flu/RSV plus?

What external quality control (QC) material options are available for Xpert Xpress CoV-2/Flu/RSV plus?

Back to Top